daunorubicin has been researched along with dinoprostone in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Kitani, T; Machii, T; Nakamura, Y; Nishimoto, M; Shibano, M; Taniguchi, N; Ueda, E; Waki, K | 1 |
Bruserud, O; Døskeland, SO; Gausdal, G; Gjertsen, BT; Havemann, U; Herfindal, L; Kleppe, R; Lanotte, M; McCormack, E; Nguyen, E; Pendino, F; Rouhee, N; Schwede, F; Ségal-Bendirdjian, E; Skavland, J; Wergeland, A | 1 |
Chien, TY; Huang, GC; Lee, CJ; Tseng, SH; Wang, CC; Wang, KT; Weng, BC | 1 |
4 other study(ies) available for daunorubicin and dinoprostone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
[A successful topical administration of prostaglandin E2 (PGE2) for the prophylaxis of chemotherapy associated oral mucosal lesions in a case of monocytic leukemia].
Topics: Administration, Topical; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Dinoprostone; Female; Humans; Leukemia, Myeloid; Mercaptopurine; Middle Aged; Mouth Mucosa; Prednisolone; Prostaglandins E; Stomatitis | 1987 |
Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Antibiotics, Antineoplastic; Apoptosis; bcl-Associated Death Protein; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinase Type I; Cyclic AMP-Dependent Protein Kinase Type II; Daunorubicin; Dinoprostone; Disease Progression; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Male; Mice; Mice, Inbred NOD; Mice, SCID; RNA Interference; RNA, Small Interfering; Theophylline; Transplantation, Heterologous; Tretinoin | 2013 |
Immunomodulatory effects of Hedysarum polybotrys extract in mice macrophages, splenocytes and leucopenia.
Topics: Animals; Astragalus Plant; Astragalus propinquus; Cell Line; Daunorubicin; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Immunologic Factors; Isoflavones; Leukopenia; Macrophages; Mice; Nitric Oxide; Plant Extracts; Proanthocyanidins; Quality Control; Spleen | 2013 |